Transparency Market Research
Hospital Acquired Bacterial Infections (HABI) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Single User License: USD 4315.5
Flat 10% Discount!! Free Customization as per your requirement You will get Custom Report at Syndicated Report price Report will be delivered with in 15-20 working days
Request Sample
Buy Now
REPORT DESCRIPTION
Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Hospital Acquired Bacterial Infections (HABI) Market”. This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Hospital acquired bacterial infections (HABI) or nosocomial infections are type of infections commonly caused by bacterial pathogens and are acquired in healthcare facilities or hospitals. These pathogens should be examined in all patients who have developed some kind of clinical deterioration unexplained during the initial diagnosis. Currently, HABI market is a lucrative market venture due to increasing incidence rate of hospital acquired infections, which makes this industry a highly profitable and attractive market. Browse Full Report with TOC: http://www.transparencymarketresearch.com/api-contract-manufacturing.html Some of the type of techniques and methods usually opted for performing various test for the diagnosis of hospital acquired bacterial infections are as follows:
DNA Sequencing
Colorimetric Methods
Microarrays
RT-PCR
Solid-phase Hybridization Techniques
Phage-based Assays
The Nitrate Reductase Assay
Phenotypic Methods
The following are the types of hospital acquired bacterial infections:
Urinary Tract Infections (UTI)
Pneumonia
Blood Stream Infections (BSI)
Surgical Site Infections
Some of the anti bacterial drug classes generally used for the treatment of HABI are as follows:
Aminoglycosides
B-Lactam Antibiotics
Lincosamides
Glycopeptides
Carbapenems
Macrolides
Lipopeptides
Polypeptides
Quinolones
Penicillins
Sulfonamides
Tetracyclines
In the geographical analysis, North America is the leading market for hospital acquired bacterial infections treatment and testing market. Due to stringent hospital regulatory policies and increased government initiatives to prevent and control various hospitalacquired infections, this region is able to maintain its dominant position across the world. Europe closely follows North America is terms of growth, due to increasing incidence of hospital-acquired infections. According to the Health Protection Agency (HPA) approximately of patients in hospitals in England acquire some form of bacterial infection during their hospital stay. However, other regions such as South East Asia, Middle East and Latin America are expected to be the promising markets in the near future. Owing to the rising disposable income among population, increasing incidence of bacterial infections and developing healthcare infrastructure, these regions are expected to be the potential market in the near future. Some of the major factors propelling the growth of Hospital Acquired Bacterial Infections (HABI) market are increasing incidence rate of hospital acquired bacterial infections and introduction of novel therapeutics that are safe and highly effective. Moreover, development of personalized medicines designed specifically according to the genetic composition of an individual is also expected to drive this market to a certain extent. It is also expected that introduction of innovative infection control devices and products, that are cost-effective would help in the market size expansion of the overall HABI market. However, patent expiries of antibacterial drugs such as Invanz, Levaquin, Zyvox and Tobi are expected to erode the hospital acquired bacterial infections market. Additionally, market-restraining factors that could hamper the growth of the market are increased hygiene surveillance in hospitals and healthcare facilities along with resistance developed against antibacterials, which makes existing antibacterial drugs archaic in some
circumstances. However, concerns focusing on product safety and effectiveness along with availability of these products are some of the factors that considerably affect the sales and growth of the hospital acquired bacterial infections market. Currently, the hospital acquired bacterial infections market is a highly fragmented market due to the involvement of many established and emerging players. Some of the key players involved in the Hospital Acquired Bacterial Infections (HABI) market are Abbott Laboratories, AstraZeneca plc, Bayer Schering Pharma AG, Becton, Dickinson and Company, Cepheid, Inc., Cubist Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Kimberly-Clark Corporation, Pfizer, Inc. and Tetraphase Pharmaceuticals, Inc. Read More Reports on Pharmaceutical Markets: http://www.transparencymarketresearch.com/pharmaceutical-market-reports1.html This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. Enquiry before Buying @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2910 About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Followed LinkedIn :- https://www.linkedin.com/today/post/article/20140805053656-349336221-hospital-acquired-bacterialinfections-habi-market Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY —12207 United States Tel: +1-518-618-1030 USA —Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com/
Website: http://www.transparencymarketresearch.com/ Browse Market Research Blogs: http://researchreportsindustry.wordpress.com/ http://marketingfirmblog.wordpress.com/